K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Kaken Pharmaceutical Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kaken Pharmaceutical Co Ltd
Retained Earnings Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
K
Kaken Pharmaceutical Co Ltd
TSE:4521
Retained Earnings
ÂĄ127.4B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
11%
Takeda Pharmaceutical Co Ltd
TSE:4502
Retained Earnings
ÂĄ1.3T
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-3%
Daiichi Sankyo Co Ltd
TSE:4568
Retained Earnings
ÂĄ1.4T
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Retained Earnings
ÂĄ1.7T
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Retained Earnings
ÂĄ1.5T
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
13%
Astellas Pharma Inc
TSE:4503
Retained Earnings
ÂĄ784.1B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
-1%

See Also

What is Kaken Pharmaceutical Co Ltd's Retained Earnings?
Retained Earnings
127.4B JPY

Based on the financial report for Jun 30, 2024, Kaken Pharmaceutical Co Ltd's Retained Earnings amounts to 127.4B JPY.

What is Kaken Pharmaceutical Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
11%

Over the last year, the Retained Earnings growth was 1%. The average annual Retained Earnings growth rates for Kaken Pharmaceutical Co Ltd have been 1% over the past three years , 4% over the past five years , and 11% over the past ten years .

Back to Top